FP-1305
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for FP-1305, covering 2025-04-02 to 2025-04-02. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Safety, Tolerability and Preliminary Efficacy of FP-1305 in Cancer Patients (MATINS) [Phase 1, Phase 2]